Welcome, Opening Remarks, and Keynote Address
Panel Discussions: Engaging Youth in Treatment and Working with Adolescents with Stimulant Use Disorder
Panel Discussions: Generational Substance Use Disorder and Prevention & Intervention in the Home & Community Designed for Youth and Children
Interactive Panel on Care Coordination Video
Summit Afternoon Session Video
DAY 1
Overview of SOR Program and Medication First Protocols
Presentation & Resources:
Florida Opioid Response Overview
Ute Gazioch
Director of Substance Abuse and Mental Health
Department of Children and Families
A presentation describing the initiatives supported by the State Opioid Response (SOR), what has been accomplished since 2018, and the plans moving forward
Additional Resources:
Florida State Opioid Response Grant by the Numbers
Alex Parodi, MSD
Epidemiologist
Department of Children and Families
A review of the data collected on the services funded by the SOR grant, including trends and accomplishments
MAT Programs Managed by FADAA
Darran M. Duchene, PsyD
Director of MAT Services
FADAA/Florida Behavioral Health Association
A review of the Medication Assisted programs operated by FADAA to treat individuals with an opioid use disorder including lessons learned
Additional Resources:
2020 MAT Provider Survey, Selected Findings
Mark Fontaine, MSW
FADAA/Florida Behavioral Health Association
Results of the 2020 survey to assess the opioid treatment practices among MAT providers for individuals with opioid use disorders (OUD) in Florida
DCF Naloxone Program Updates
Amanda Muller
Overdose Prevention Coordinator
Department of Children and Families
Review of the efforts toward increasing access to Naloxone, including the program’s goals and accomplishments
Additional Resources:
Panel of Missouri Providers on Medication First Protocols
Ryan Essex
Chief Operating Officer
Gibson Recovery Center, Inc.
Clif Johnson, CRAAD
Chief Stakeholder Relations Officer
Southeast Missouri Behavioral Health
Corinna L. Putz, MBA, CSAC
Executive Vice President
Preferred Family Healthcare
Missouri treatment providers discuss the challenges, successes, and the reception of the program experienced during the implementation of the Medication First model within their treatment practices
Additional Resources:
DAY 2
Treatment Retention and Treating Stimulant Use Disorders
Presentation & Resources:
Retaining Individuals in Treatment
Alex Parodi, MSD
Epidemiologist
Department of Children and Families
A review of the retention data including the primary reasons for discharge, patient outcomes related to retention, and a look ahead
Engagement & Retention Strategies MAT for Opioid Use Disorder: Innovative Models for Enhancing Retention and Continuity of Care
Peggy O’Brien, PhD
Senior Research Leader
IBM Watson Health
A discussion of a study examining models and strategies for retaining individuals in treatment and enhancing continuity of care across settings including geographically diverse opioid treatment programs; specialty and non-specialty providers of buprenorphine; home-delivery of injectable naltrexone; provider offering of a spectrum of SUD, mental and physical health care, housing and employment services; and a large health system working closely with the criminal justice system
Additional Resources:
Evidence-based Practices in Treating Stimulants
Richard Rawson, Ph.D.
UCLA Department of Psychiatry
IBM Watson Health
A presentation discussing how evidence-based practices such as Contingency Management, Cognitive Behavioral Therapy, Community Reinforcement Approach, Motivational Interviewing, and physical exercise support treatment efforts for individuals with Stimulant Use Disorder (StUD) involving both prescription and illicit stimulants, such as cocaine and amphetamines
Additional Resources:
Video 1: State Opioid Response
Video 1a: Where We Are
Video 2: Defining Success
Video 3: Florida’s Response
Video 4: Effective Utilization
Video 5: Engaging Patients into MAT Services
Video 6: Retaining Patients In MAT
Video 7: Utilizing Peers in MAT
Video 1: Treating Opioid Addiction and STR Opioid Funding
Video 2: The Opioid Addicted Brain and Medication Assisted Treatment
Video 3: Operating Medication Assisted Treatment Programs
Video 4: Hospital Diversion Programs
Video 5: Effective Engagement of Patients
Video 6: Utilizing Peers
Video 7: Next Steps